Guardian Technologies poised to enter tuberculosis pathology market

HealthImaging reports Guardian Technologies poised to enter tuberculosis pathology market:

Guardian has expanded its relationship with the Aurum Institute for Health Research to include collaboration on product development and commercialization, as well as marketing and distribution rights in South Africa for Guardian's prototype designed to automatically detect and quantify tuberculosis.

...

Using Signature Mapping technology integrated into a digital pathology workflow system will improve diagnostic detection accuracy, reduce diagnostic processing time and lower the cost to analyze sputum microscopy specimens for tuberculosis, according to the company.

This is pretty cool, more and more companies are devising clinical tests based on digital pathology.  Many of them are software tests rather than chemical tests - a pretty amazing transformation...